Clinical utility of gene-expression signatures in early stage breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of gene-expression signatures in early stage breast cancer
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 14, Issue 10, Pages 595-610
Publisher
Springer Nature
Online
2017-05-31
DOI
10.1038/nrclinonc.2017.74
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
- (2016) John M. S. Bartlett et al. JNCI-Journal of the National Cancer Institute
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
- (2016) John M. S. Bartlett et al. JNCI-Journal of the National Cancer Institute
- The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence
- (2016) Michail Ignatiadis et al. JAMA Oncology
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- Long-term impact of the 70-gene signature on breast cancer outcome
- (2014) C. A. Drukker et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis
- (2014) C. A. Drukker et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis
- (2014) S Ward et al. HEALTH TECHNOLOGY ASSESSMENT
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2014) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue
- (2014) Anna Sapino et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Biomarker validation and testing
- (2014) Daniel F. Hayes Molecular Oncology
- Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†
- (2013) H. A. Azim et al. ANNALS OF ONCOLOGY
- Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
- (2013) M. Gnant et al. ANNALS OF ONCOLOGY
- Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes
- (2013) M. Saghatchian et al. BREAST
- Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses
- (2013) Roman Rouzier et al. BREAST CANCER RESEARCH AND TREATMENT
- The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients
- (2013) P Dubsky et al. BRITISH JOURNAL OF CANCER
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prospective cost-effectiveness analysis of genomic profiling in breast cancer
- (2013) V.P. Retèl et al. EUROPEAN JOURNAL OF CANCER
- Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
- (2013) N. Harbeck et al. EUROPEAN JOURNAL OF CANCER
- A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
- (2013) C.A. Drukker et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
- (2013) Dennis C. Sgroi et al. JNCI-Journal of the National Cancer Institute
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
- (2012) P. Dubsky et al. ANNALS OF ONCOLOGY
- Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
- (2012) Ralf Kronenwett et al. BMC CANCER
- Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
- (2012) Nathan W. D. Lamond et al. BREAST CANCER RESEARCH AND TREATMENT
- Cost effectiveness of gene expression profiling for early stage breast cancer
- (2012) Mo Yang et al. CANCER
- The EORTC Cancer in the Elderly Task Force, a Protostar for EORTC's future
- (2012) Hans Wildiers et al. EJC SUPPLEMENTS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX(R)) and the PAM50 Breast Cancer Intrinsic Classifier in Early-Stage Estrogen Receptor-Positive Breast Cancer
- (2012) C. M. Kelly et al. ONCOLOGIST
- NanoStriDE: normalization and differential expression analysis of NanoString nCounter data
- (2011) Christopher D Brumbaugh et al. BMC BIOINFORMATICS
- Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
- (2011) P-L Jerevall et al. BRITISH JOURNAL OF CANCER
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Profiles from Formalin Fixed Paraffin Embedded Breast Cancer Tissue Are Largely Comparable to Fresh Frozen Matched Tissue
- (2011) Lorenza Mittempergher et al. PLoS One
- Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers
- (2010) Catherine M. Kelly et al. CANCER
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer
- (2010) Valesca P. Retèl et al. EUROPEAN JOURNAL OF CANCER
- Outcomes of interest in evidence-based evaluations of genetic tests
- (2010) Jeffrey R Botkin et al. GENETICS IN MEDICINE
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- (2010) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice
- (2009) J. M. Bueno-de-Mesquita et al. ANNALS OF ONCOLOGY
- The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
- (2009) S. Mook et al. ANNALS OF ONCOLOGY
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
- (2009) Steven M Teutsch et al. GENETICS IN MEDICINE
- Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer
- (2009) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
- (2009) Kathy S Albain et al. LANCET
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
- (2008) Stella Mook et al. BREAST CANCER RESEARCH AND TREATMENT
- Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
- (2008) B. S. Wittner et al. CLINICAL CANCER RESEARCH
- Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B14 and B20 Trials
- (2008) D. T. Ross et al. CLINICAL CANCER RESEARCH
- A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer
- (2008) X.-J. Ma et al. CLINICAL CANCER RESEARCH
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North American Breast Cancer Intergroup Trial E 2197
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now